聚多卡醇联合阿替洛尔治疗婴幼儿腮腺区血管瘤的临床研究

doi:10.3969/j.issn.1007-3205.2020.02.013

河北医科大学学报

聚多卡醇联合阿替洛尔治疗婴幼儿腮腺区血管瘤的临床研究

1.河北省人民医院小儿外科,河北石家庄 050051;2.河北省人民医院病理科,河北石家庄 050051；
3.河北省邯郸市第七医院普外科,河北邯郸 056000

出版日期:2020-02-25 发布日期:2020-03-13
作者简介:李蕾（1978-），男，河北石家庄人，河北省人民医院主治医师，医学学士，从事小儿外科疾病诊治研究。
基金资助:
河北省医学科学研究重点课题计划(20100170)

Effect of polypolycarnitol combined with Atenolol in treatment of infantile hemangioma in parotid region and its effect on COX-2,CTGF#br#

1.Deparment of Pediatric Surgery, Hebei General Hospital, Shijiazhuang 050051, China;
2.Department of Pathology, Hebei General Hospital, Shijiazhuang 050051, China;
3.Deparment of General Surgery, Handan 7th Hospital,
Hebei Province, Handan 056000, China

Online:2020-02-25 Published:2020-03-13

摘要/Abstract

摘要： ［摘要］
目的探讨聚多卡醇联合阿替洛尔治疗婴幼儿腮腺区血管瘤的疗效及其对环氧化酶2（cyclooxygenase 2，COX-2）、结缔组织生长因子（connective tissue growth factor，CTGF）、血管内皮生长因子（vascular endothelial growth factor，VEGF）的影响。
方法选取腮腺区血管瘤患儿76例，随机分为对照组（38例）和观察组（38例），对照组患儿给予阿替洛尔治疗，观察组患儿在此基础上给予瘤内局部注射1%聚多卡醇治疗。比较2组临床疗效及不良反应发生情况，比较治疗前后2组患儿COX-2、CTGF阳性率、VEGF水平及免疫功能。
结果 2组患儿平均服用阿替洛尔6个月，观察组患儿平均注射1%聚多卡醇3个疗程。76例患儿均完成治疗，随访12个月无失访。观察组总有效率显著高于对照组（P＜0.05）。治疗完成后观察组VEGF水平及COX-2、CTGF阳性率显著低于对照组，观察组IgA、IgG及IgM水平均显著高于对照组（P＜0.05）。治疗期间，观察组不良反应发生率显著低于对照组（P＜0.05）。
结论聚多卡醇联合阿替洛尔治疗婴幼儿腮腺区血管瘤效果良好，且安全性高，具有抑制COX-2、CTGF及VEGF表达的作用。

关键词: 血管瘤, 腮腺区, 阿替洛尔, 环氧化酶2

Abstract: ［Abstract］ Objective To study the effect of polypolycarnitol combined with Atenolol in treatment of infantile hemangioma in parotid region and its effect on cyclooxygenase 2(COX-2), connective tissue growth factor(CTGF), vascular endothelial growth factor（VEGF）.
Methods Seventy-six patients with hemangioma of parotid gland were randomly divided into control group(38 cases) and observation group(38 cases). In the control group, the children were treated with atenolol, and the observation group was given a local injection of 1% polykarl in the tumor. The clinical efficacy and adverse reactions were compared between two groups.The expression of COX-2, CTGF and VEGF and immune function were compared between two groups of children before and after treatment.
Results The two groups took atenolol for an average of 6 months, and the observation group received 1% polycarnitol for 3 courses on average.The treatment was completed in 76 children, followed up for 12 months without loss of follow-up. The total effective rate of observation group was significantly higher than that of control group(P＜0.05). After treatment, the positive rate of COX-2,CTGF and the level of VEGF in observation group were significantly lower than those in control group. The levels of IgA,IgG and IgM in observation group were significantly higher than those in control group(P＜0.05). During the treatment period, compared with the control group, the adverse reactions in observation group were significantly lower(P＜0.05).
Conclusion Atenolol combined with polycarnitol is effective and safe in the treatment of infantile hemangioma in parotid region. It can inhibit the expression of COX-2, CTGF and VEGF.

Key words: hemangioma, parotid region, atenolol, cyclooxygenase 2

李蕾1，梁巍1，陈琛2，张红鹏3. 聚多卡醇联合阿替洛尔治疗婴幼儿腮腺区血管瘤的临床研究[J]. 河北医科大学学报, doi: 10.3969/j.issn.1007-3205.2020.02.013.

LI Lei1, LIANG Wei1, CHEN Chen2, ZHANG Hong-peng3. Effect of polypolycarnitol combined with Atenolol in treatment of infantile hemangioma in parotid region and its effect on COX-2,CTGF#br#[J]. Journal of Hebei Medical University, doi: 10.3969/j.issn.1007-3205.2020.02.013.

[1]	向伟, 孙聪欣, 陈桂红, 关晶, 王礼贤. 超声诊断为胎盘绒毛膜血管瘤的临床特征和妊娠结局的研究[J]. 河北医科大学学报, 2023, 44(6): 702-706.
[2]	高妹花, 刘学英, 高阳, 李攀, 王会肖. 口服普萘洛尔治疗婴幼儿血管瘤的效果观察[J]. 河北医科大学学报, 2021, 42(12): 1432-1436.
[3]	张文显1，杨伊帆1，薛〓磊1，高〓阳1*，王〓乐2，曹敏娜1. 脉冲染料激光治疗新生儿期婴幼儿血管瘤的效果观察[J]. 河北医科大学学报, 2017, 37(7): 786-788.
[4]	张永婷，费〓川（综述），徐伟立*（审校）. 血管生成在婴幼儿血管瘤发病及治疗中的研究进展[J]. 河北医科大学学报, 2016, 37(9): 1112-1116.
[5]	孔文杰1，师宏山1*，鹿梦溪2. 2种硬化剂超声引导下经皮穿刺注射治疗肝血管瘤疗效分析[J]. 河北医科大学学报, 2016, 37(6): 706-709.
[6]	张大为,何津,张海光,张青云,王莉丽,马龙滨. 腹腔镜下射频消融治疗肝海绵状血管瘤[J]. 河北医科大学学报, 2016, 37(2): 229-231.
[7]	王佳蓉;吴瑞珊;曾冰微. 基质金属蛋白酶2、环氧化酶2表达在下咽癌转移中的作用[J]. , 2015, 36(10): 1207-1207.
[8]	杜国辉;曹冬梅;于桂兰;杨建春;郅春富. 复方夏枯草搽剂联合平阳霉素治疗婴幼儿血管瘤的疗效观察[J]. , 2013, 34(8): 964-964.
[9]	张兰平;李宗良. 32P敷贴器再利用治疗婴幼儿单纯性血管瘤的疗效观察[J]. , 2013, 34(7): 789-789.
[10]	楼天奇;姚列锋. 肺硬化性血管瘤的CT表现[J]. , 2013, 34(2): 178-178.
[11]	杜国辉;曹冬梅;郅伟;杨建春;郅春富. 平阳霉素加曲安奈德治疗小儿颌面部血管瘤临床体会[J]. , 2012, 33(7): 858-858.
[12]	徐泉平. CT动态增强扫描在眼眶海绵状血管瘤诊断中的价值[J]. , 2012, 33(11): 1340-1340.
[13]	董长征;赵文清;李文玲. 成功抢救癫痫持续状态1例[J]. , 2009, 30(9): 868-868.
[14]	常世民;柳春明;张方明. 腮腺区面神经鞘瘤的诊断与治疗(附8例报告)[J]. , 2009, 30(5): 475-475.
[15]	徐晓青;王鹏;王玉红;杨广承;马桂琴;刘爱亚. MMP-2与TIMP-2在血管瘤不同时期的表达[J]. , 2009, 30(3): 249-249.

聚多卡醇联合阿替洛尔治疗婴幼儿腮腺区血管瘤的临床研究

Effect of polypolycarnitol combined with Atenolol in treatment of infantile hemangioma in parotid region and its effect on COX-2,CTGF#br#

HTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价